REG-BARCLAYS PLC FORM 8.3 - 2021-03-31 IRISH TOP 8.3 REPORT AON - AMENDMENT
06/04/2021 14:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210406:nBwcf12JNa&default-theme=true
FORM 8.3 - 2021-03-31 IRISH TOP 8.3 REPORT AON - AMENDMENT
Ap19
FORM 8.3 - Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 31 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
458,904 0.20% 1,778,292 0.79%
(2) Derivatives (other than options):
95,497 0.04% 13,657 0.01%
(3) Options and agreements to
purchase/sell: 24,200 0.01% 24,200 0.01%
TOTAL:
578,601 0.26% 1,816,149 0.80%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 230.4400 USD
Purchase 1 230.1000 USD
Purchase 1 230.3700 USD
Purchase 2 231.0900 USD
Purchase 2 231.0500 USD
Purchase 2 230.2750 USD
Purchase 4 230.2425 USD
Purchase 5 230.3720 USD
Purchase 16 231.7300 USD
Purchase 21 230.7052 USD
Purchase 42 232.6800 USD
Purchase 45 230.0200 USD
Purchase 50 232.7400 USD
Purchase 51 230.2400 USD
Purchase 68 232.2200 USD
Purchase 101 230.4000 USD
Purchase 130 230.1276 USD
Purchase 200 231.7650 USD
Purchase 233 232.4710 USD
Purchase 300 230.6400 USD
Purchase 322 230.8500 USD
Purchase 388 232.3509 USD
Purchase 400 230.6825 USD
Purchase 400 232.4362 USD
Purchase 400 230.3925 USD
Purchase 421 232.6823 USD
Purchase 453 230.5630 USD
Purchase 600 230.3340 USD
Purchase 617 231.2392 USD
Purchase 824 230.6356 USD
Purchase 1,500 230.7473 USD
Purchase 1,800 230.5594 USD
Purchase 2,000 230.6583 USD
Purchase 3,103 230.3213 USD
Purchase 3,529 231.2296 USD
Purchase 4,104 230.6246 USD
Purchase 5,865 230.5615 USD
Purchase 6,251 231.1571 USD
Purchase 9,682 230.2069 USD
Purchase 10,800 231.3539 USD
Purchase 16,234 230.7122 USD
Purchase 24,474 230.7356 USD
Purchase 27,089 230.1100 USD
Sale 1 231.4050 USD
Sale 1 230.3700 USD
Sale 2 231.0500 USD
Sale 2 231.8300 USD
Sale 8 232.3600 USD
Sale 10 230.6750 USD
Sale 16 231.7300 USD
Sale 30 230.7245 USD
Sale 37 230.5645 USD
Sale 45 230.5505 USD
Sale 50 232.2700 USD
Sale 65 230.2180 USD
Sale 68 232.2200 USD
Sale 70 230.8528 USD
Sale 71 230.9391 USD
Sale 95 230.6357 USD
Sale 95 230.5757 USD
Sale 100 230.1200 USD
Sale 100 231.5000 USD
Sale 100 232.0300 USD
Sale 115 230.8663 USD
Sale 133 231.2102 USD
Sale 150 230.6516 USD
Sale 174 231.7444 USD
Sale 185 230.6416 USD
Sale 200 230.6294 USD
Sale 227 230.6774 USD
Sale 245 230.4730 USD
Sale 300 230.3340 USD
Sale 301 230.8450 USD
Sale 416 231.1621 USD
Sale 800 231.2870 USD
Sale 922 230.5885 USD
Sale 1,021 231.5287 USD
Sale 1,064 230.7228 USD
Sale 1,281 229.8993 USD
Sale 1,458 230.1117 USD
Sale 1,634 232.5034 USD
Sale 1,741 231.3720 USD
Sale 1,927 230.1330 USD
Sale 2,363 231.2798 USD
Sale 2,380 231.2793 USD
Sale 2,505 231.0995 USD
Sale 2,925 231.5283 USD
Sale 4,372 230.3247 USD
Sale 4,551 230.5899 USD
Sale 5,318 231.2580 USD
Sale 10,111 230.3074 USD
Sale 27,324 230.1100 USD
Sale 46,753 230.7365 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 6 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -1,200 220.0000 American Jul 16, 2021
Call Options Purchased 1,200 240.0000 American Jul 16, 2021
Call Options Purchased 23,000 220.0000 American Jul 16, 2021
Put Options Purchased -23,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210406005706/en/
(https://www.businesswire.com/news/home/20210406005706/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC Qualcomm Inc - Form 8.3 QUALCOMM INC
AnnouncementREG - Barclays PLC Dalata Hotel Group - Form 8.3 - DALATA HOTEL GROUP PLC
AnnouncementREG - Barclays PLC Alphawave IP Group - Form 8.3 ALPHAWAVE IP GROUP PLC
AnnouncementREG - Barclays PLC Alpha Group Intl PLC - Form 8.3 ALPHA GROUP INTERNATIONAL PLC
AnnouncementREG - Barclays PLC Spirent Comms. PLC - Form 8.3 SPIRENT COMMUNICATIONS PLC
Announcement